Glucocorticoid Receptor-? Is Downregulated by Vitamin D Treatment in Children with Low Vitamin D Levels but Not in Allergic Asthma

Basit Öğe Kaydı
dc.contributor.authorGuner, Sukru Nail
dc.contributor.authorSancak, Recep
dc.contributor.authorGulten, Sedat
dc.contributor.authorOzen, Ahmet
dc.contributor.authorKilic, Mehtap
dc.contributor.authorBedir, Abdulkerim
dc.date.accessioned2024-02-23T14:20:58Z
dc.date.available2024-02-23T14:20:58Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstractBackground: Vitamin D (VitD) enhances the anti-inflammatory effects of glucocorticoids (GC) in vitro. It was hypothesized that VitD3 (colecalciferol) treatment could have an impact on the expression of glucocorticoid receptors (GRs) in a group of children with low VitD levels, with or without asthma. Methods: Asthmatic children and healthy controls, all with low serum VitD levels (25-hydroxyvitamin D [25(OH)D] level <30 ng/mL) were recruited. VitD3 treatment at a dose of 300,000 IU was given orally. Blood samples were obtained at admission and 1 month after the treatment to examine serum 25(OH)D levels and the relative gene expression (RGE) of GR-alpha and -beta in peripheral blood mononuclear cells. Results: Twenty-four children with asthma (M-age 11.1 +/- 2.1 years) and 14 healthy controls (M-age 11.5 +/- 1.7 years) were studied. The expression of GR-beta was significantly higher in the control group at baseline compared with those with asthma (p = 0.006). With VitD3 treatment, there was a decrease in GR beta expression at 1 month in the control group (p = 0.05), but not in the asthma group. When analyzing the change in the relative expression of GR beta (change in 1st month to baseline), the decrease in GR beta was significantly higher in the control group compared with the asthma group (p = 0.002). A negative correlation was detected between the change in the asthma control test score (ACT) and the change in 25(OH)D values (r = -0.51, p = 0.01). Conclusion: VitD3 supplementation led to a decrease in the expression of GR beta in control subjects with low baseline VitD levels, whereas no such change was observed in asthmatic children. Meanwhile, better asthma control was achieved by VitD3 treatment, possibly through mechanisms not related to GR expression.en_US
dc.description.sponsorshipOndokuz Mayis University Study Grant [PYO.TIP.1904.10.044]en_US
dc.description.sponsorshipWe thank Prof. Yuksel Bek from the Department of Biostatistics, Ondokuz Mayis University, Samsun, Turkey, for his important contributions to the statistics. This study was supported by Ondokuz Mayis University Study Grant (project no. PYO.TIP.1904.10.044).en_US
dc.identifier.doi10.1089/ped.2015.0506
dc.identifier.endpage151en_US
dc.identifier.issn2151-321X
dc.identifier.issn2151-3228
dc.identifier.issue3en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage144en_US
dc.identifier.urihttps://doi.org/10.1089/ped.2015.0506
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13387
dc.identifier.volume28en_US
dc.identifier.wosWOS:000361377000002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofPediatric Allergy Immunology And Pulmonologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleGlucocorticoid Receptor-? Is Downregulated by Vitamin D Treatment in Children with Low Vitamin D Levels but Not in Allergic Asthmaen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu